Quadrature Capital’s Cellebrite CLBT Stock Holding History

Quadrature Capital’s Portfolio CLBT Stock Details CLBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$182K	Buy	+12,446	New	+$164K	﹤0.01%	1376
2025 Q3	–	Sell	-11,635	Closed	-$186K	–	1097
2025 Q2	$186K	Sell	11,635 -10,546	-48%	-$188K	﹤0.01%	825
2025 Q1	$431K	Sell	22,181 -3,719	-14%	-$78.3K	0.01%	620
2024 Q4	$571K	Sell	25,900 -12,988	-33%	-$250K	0.01%	554
2024 Q3	$654K	Sell	38,888 -63,052	-62%	-$936K	0.01%	444
2024 Q2	$1.22M	Sell	101,940 -124,175	-55%	-$1.39M	0.02%	410
2024 Q1	$2.5M	Sell	226,115 -30,287	-12%	-$309K	0.04%	268
2023 Q4	$2.22M	Buy	256,402 +125,913	+96%	+$979K	0.04%	232
2023 Q3	$998K	Buy	130,489 +80,142	+159%	+$602K	0.02%	419
2023 Q2	$362K	Buy	+50,347	New	+$294K	0.01%	665

Other funds holding CLBT

TWCM

True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return

Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return

Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Quadrature Capital's CLBT Position: Q2 2026 in Review

Quadrature Capital opened a new position in Cellebrite (CLBT) in Q2 2026: 12,446 shares worth $182K. The stake represents ﹤0.01% of the portfolio and ranks #1376 among its holdings. This is a return to the name: Quadrature Capital previously reported a position in CLBT as recently as Q2 2025.

Quadrature Capital first reported a position in CLBT in Q2 2023 and has held it in 10 quarters since. The position peaked at $2.5M in Q1 2024. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

Quadrature Capital held 12,446 shares of Cellebrite worth $182K as of Q2 2026.
Cellebrite was a new Quadrature Capital position in Q2 2026.
Cellebrite made up ﹤0.01% of Quadrature Capital's portfolio in Q2 2026, its #1376 holding.
Quadrature Capital first reported a position in Cellebrite in Q2 2023 and has held it in 10 quarters since.
Quadrature Capital's Cellebrite position peaked at $2.5M in Q1 2024.
201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.